First Nebraska Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.8M | Buy |
7,172
+54
| +0.8% | +$11.6K | 0.15% | 88 |
|
|
2026
Q1 | $1.55M | Sell |
7,118
-35
| -0.5% | -$7.76K | 0.14% | 87 |
|
|
2025
Q4 | $1.63M | Buy |
7,153
+850
| +13% | +$194K | 0.15% | 86 |
|
|
2025
Q3 | $1.46M | Hold |
6,303
| – | – | 0.13% | 89 |
|
|
2025
Q2 | $1.13M | Buy |
6,303
+200
| +3% | +$37.2K | 0.11% | 99 |
|
|
2025
Q1 | $1.28M | Buy |
6,103
+190
| +3% | +$36.9K | 0.13% | 93 |
|
|
2024
Q4 | $1.05M | Hold |
5,913
| – | – | 0.1% | 98 |
|
|
2024
Q3 | $1.17M | Sell |
5,913
-120
| -2% | -$22.4K | 0.11% | 97 |
|
|
2024
Q2 | $1.03M | Sell |
6,033
-40
| -0.7% | -$6.63K | 0.11% | 98 |
|
|
2024
Q1 | $1.11M | Buy |
6,073
+245
| +4% | +$42.2K | 0.11% | 93 |
|
|
2023
Q4 | $903K | Buy |
5,828
+20
| +0.3% | +$2.92K | 0.1% | 96 |
|
|
2023
Q3 | $866K | Hold |
5,808
| – | – | 0.11% | 91 |
|
|
2023
Q2 | $783K | Buy |
5,808
+100
| +2% | +$14.7K | 0.09% | 94 |
|
|
2023
Q1 | $910K | Buy |
5,708
+120
| +2% | +$18.3K | 0.11% | 87 |
|
|
2022
Q4 | $903K | Buy |
5,588
+195
| +4% | +$29.9K | 0.12% | 88 |
|
|
2022
Q3 | $724K | Sell |
5,393
-7
| -0.1% | -$1K | 0.1% | 90 |
|
|
2022
Q2 | $827K | Sell |
5,400
-30
| -0.6% | -$4.58K | 0.11% | 89 |
|
|
2022
Q1 | $880K | Sell |
5,430
-1,500
| -22% | -$218K | 0.1% | 91 |
|
|
2021
Q4 | $938K | Sell |
6,930
-143
| -2% | -$16.9K | 0.11% | 85 |
|
|
2021
Q3 | $763K | Buy |
7,073
+150
| +2% | +$17.1K | 0.1% | 90 |
|
|
2021
Q2 | $780K | Buy |
6,923
+150
| +2% | +$16.9K | 0.1% | 90 |
|
|
2021
Q1 | $733K | Sell |
6,773
-348
| -5% | -$37.2K | 0.1% | 94 |
|
|
2020
Q4 | $763K | Sell |
7,121
-329
| -4% | -$31.6K | 0.11% | 87 |
|
|
2020
Q3 | $653K | Hold |
7,450
| – | – | 0.11% | 91 |
|
|
2020
Q2 | $731K | Buy |
7,450
+317
| +4% | +$27.9K | 0.14% | 85 |
|
|
2020
Q1 | $543K | Buy |
+7,133
| New | +$608K | 0.12% | 87 |
|
|
2014
Q2 | – | Sell |
-4,576
| Closed | -$235K | – | 103 |
|
|
2014
Q1 | $235K | Sell |
4,576
-375
| -8% | -$19K | 0.07% | 81 |
|
|
2013
Q4 | $261K | Hold |
4,951
| – | – | 0.08% | 81 |
|
|
2013
Q3 | $221K | Sell |
4,951
-500
| -9% | -$22.2K | 0.08% | 83 |
|
|
2013
Q2 | $225K | Buy |
+5,451
| New | +$238K | 0.08% | 82 |
|
Other funds holding ABBV
First Nebraska Trust's ABBV Position: Q2 2026 in Review
First Nebraska Trust increased its AbbVie (ABBV) stake by 0.76% in Q2 2026, buying an estimated $11.6K and bringing the position to 7,172 shares worth $1.8M. The position accounts for 0.15% of the portfolio, ranked #88.
First Nebraska Trust first reported a position in ABBV in Q2 2013 and has held it in 30 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- First Nebraska Trust held 7,172 shares of AbbVie worth $1.8M as of Q2 2026.
- First Nebraska Trust bought 54 AbbVie shares in Q2 2026, an estimated $11.6K.
- AbbVie made up 0.15% of First Nebraska Trust's portfolio in Q2 2026, its #88 holding.
- First Nebraska Trust first reported a position in AbbVie in Q2 2013 and has held it in 30 quarters since.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on First Nebraska Trust's 13F filing for Q2 2026, filed 12 Aug 2026.